Chosen by Independent Expert Panel at the 2018 Cambridge Independent Science and Technology Awards. Elpis Biomed Ltd. (Elpis), a University of Cambridge spin-out developing high quality human cells via its proprietary OPTi-OX platform, is pleased to announce that the Company has been selected as winner in the category Start-Up of the Year at the 2018 Cambridge Independent Science and Technology Awards...
New microscopy technologies, such as light sheet fluorescence microscopy (LSFM) or clearing methods, allow the imaging of large samples at high resolution or high frame rates. Handling, processing, and analyzing these multi-terabyte data sets has become increasingly difficult for scientists, e.g. in developmental biology and neuroscience. New tools are needed to overcome these challenges. Therefore, EISS has teamed up with arivis AG to offer complete solutions from initial image acquisition to final results...
Markes International’s outstanding success in exporting scientific instrumentation has been rewarded with an accolade from the UK’s Department for International Trade (DIT). The Board of Trade Awards, which are nominated and selected by the DIT, were this year awarded to eight Welsh businesses showing exceptional innovation, delivering prosperity to their local communities, and championing free trade...
Oxford Gene Technology (OGT), The Molecular Genetics Company, has announced that it has expanded its direct sales of Cytocell Fluorescence In Situ Hybridisation (FISH) products to include the Asia-Pacific (APAC) region. OGT will provide customers in Singapore, Malaysia, Vietnam, Australia, and New Zealand with enhanced local sales and support services via established affiliates of Sysmex Corporation, as well as via continued collaboration with existing distributors...
David Raunig, PhD brings decades of pharmaceutical research experience. ERT, a global data and technology company that minimizes uncertainty and risk in clinical trials, has announced the addition of David Raunig, PhD to its team of scientific and technological imaging experts. The science team is a key component of ERT’s rapidly growing advanced technology imaging solution, which has been used in more than 500 clinical studies to date...
For scientists who are looking for targeted exploration of new applications in the therapy of microbial and viral infection, cancer, and sepsis, now they can easily find antimicrobial peptides (AMPs) synthesis service at Creative Peptides. With extensive experience in the development, registration, production and post-launch support of peptides during the last two decades and more, Creative Peptides can offer a wide range of AMPs to fully support scientists’ projects. High quality and flexible scale are ensured....
Sygnature Discovery, a leading independent integrated drug discovery and pre-clinical services company, has today announced a multi-target, integrated drug discovery collaboration with Sitryx Therapeutics, a biopharmaceutical company focused on regulating cell metabolism to develop disease-modifying therapeutics in immuno-oncology and immuno-inflammation. The energetic status of cells has been shown to be pivotal in controlling the...
ERS Genomics Limited and DefiniGEN Ltd announced today a license agreement to provide DefiniGEN with access to ERS Genomic’s CRISPR/Cas9 genome editing technology patents. DefiniGEN will combine their best-in-class iPSC (induced Pluripotent Stem Cell) differentiation platform with CRISPR/Cas9 technology to generate a range of innovative preclinical human models. "The company’s gene editing technical portfolio has been further strengthened by licensing of this cutting-edge technology and will allow us....
SLS has been identified as one of London Stock Exchange Group’s 1000 Companies to Inspire Europe. The report is a celebration of high-growth and most dynamic small and medium sized businesses across Europe. To be included in the list, companies needed to show consistent revenue growth over a minimum of three years, significantly outperforming their country peers. More detail on the methodology can be found in the report online....
The UK’s Artificial Intelligence revolution gets new backing, as the Business Secretary announces five new centres of excellence for digital pathology and imaging, including radiology, using AI medical advances. The centres will use AI, an area the government is backing in its modern Industrial Strategy, to find new ways to speed up diagnosis of diseases to improve outcomes for patients. The centres will be spearheaded by some of the UK’s leading medical companies including GE Healthcare, Siemens, Philips, Leica, Canon and Roche Diagnostics....
Optibrium™, a developer of software for drug discovery, has announced it had entered into a collaboration with the University of Nottingham, a pioneering research institution and university. Optibrium’s StarDrop™ software will be available to a number of 4th year MSci Chemistry project students at the University of Nottingham as part of their training in modern drug discovery to aid in the design of potential new candidate compounds for integrin inhibition in fibrotic diseases and malaria, as part of their collaboration with GSK....
How do you package your send-away pathology samples? Are you spending too much time and money on packaging your samples correctly? If you are currently wrapping tubes and using boxes to transport samples by courier or Royal Mail, this could be costing you a lot more and taking much longer than necessary. The Transport of Dangerous Goods Regulations require patient specimens and other biological samples to be transported according to UN3373 Biological Substance Category B, P650 Packaging Instruction...
With the concerted efforts of its scientists, BOC Sciences recently released fluorescent labeling service to facilitate the research work in the scientific community, adding to its already existing service portfolio encompassing custom synthesis, process R&D, bioconjugation, carbohydrate synthesis, and more. Fluorescent labelling is the process of covalently binding fluorescent dyes to biomolecules such as nucleic acids or proteins so that they can be visualized by fluorescence imaging....
Lab Innovations, the UK’s only trade show dedicated to the laboratory industry, beat all records for the show, attracting 3,113 attendees - a 10% increase on the previous year. Underlying the headline number were significant increases in visitors involved in purchasing products and services. Overall, 79% of visitors were involved in the purchasing decision, with a 43% increase in lab managers, a 53% increase in lab technicians, and an impressive 125% increase in procurement managers. In addition, the number of scientists attending increased by 49%...
Scotland is to have its own £15.8m artificial intelligence health research centre, which promises to enable better patient diagnosis, treatment and outcomes. The Industrial Centre for Artificial Intelligence Research in Digital Diagnostics, to be known as iCAIRD, brings together a pan-Scotland collaboration of 15 partners from across academia, the NHS, and industry. Greg Clark, UK Secretary of State for Business, Energy and Industrial Strategy (BEIS), announced that UK Research and Innovation will invest £10million in iCAIRD...
Oxford HighQ, a spinout from Oxford University, aims to revolutionise chemical and nanoparticle sensor technology with ‘quantum’ sensors up to 10,000 times more sensitive than current counterparts. Oxford HighQ, a quantum technologies spinout from Oxford University, has launched with £2.1m in seed funding to commercialise components of quantum computing technology developed at the University, providing a step change in performance for chemical and nanoparticle sensing....
BioAscent’s COO, Sylviane Boucharens named in top 50 Movers and Shakers in BioBusiness. BioAscent Discovery Limited’s COO, Dr Sylviane Boucharens, has been included in the BioBeat 2018 list of 50 Movers and Shakers in BioBusiness. Her nomination follows an incredibly successful year in which she has spearheaded the company’s expansion to become a fully integrated drug discovery CRO. Co-founded by Dr Boucharens in 2013, BioAscent initially focused on compound management....
Absolute Antibody Ltd., specialists in antibody sequencing, engineering and recombinant expression with a vision to make recombinant antibody technology accessible to all, has announced the opening of a new facility in northeast England. The new facility more than doubles Absolute Antibody’s laboratory space and will enable an even greater increase in its antibody production capacity, allowing the company to better service customers and accelerate the expansion of its recombinant antibody portfolio....
DefiniGEN Ltd are pleased to announce the commercial licensing of CRISPR-Cas9 gene-editing technology from Broad Institute of MIT and Harvard in the USA, to develop human cell disease models to support preclinical metabolic disease therapeutic programmes. Broad Institute CRISPR-Cas9 technology will be combined with DefiniGEN’s best-in-class induced Pluripotent Stem Cell (iPSC) differentiation platform to generate preclinical cell models which can accelerate....
Platform Patent for Clustering a Subset of Antigens for Diagnosing Diseases. ImmunArray, a molecular diagnostic company co-headquartered in Rehovot, Israel and Richmond, Virginia, whose novel blood tests are pioneering new and more accurate ways to diagnose diseases detected by changes in the immune system, has announced that the U.S. Patent and Trademark Office (USPTO) recently issued a new patent that covers one of ImmunArray’s core diagnostic protocols – generic methods....
Frost & Sullivan has presented INTEGRA Biosciences with the ‘2018 Global Laboratory Pipetting Company of the Year’ award, recognizing its products as innovative, revolutionary and able to fulfil the needs of customers. Frost & Sullivan’s transformational health research group conducted extensive research using key benchmarking criteria across two main areas – visionary impact and performance, and customer impact – to compare companies in the industry, and found that INTEGRA surpassed the competition....
The biocluster located in the Greater Paris region is the first European park to receive the Association of University Research Parks (AURP) award. Genopole, a French biocluster dedicated to research in the fields of genetics and biotechnology, today announces it has received the AURP Award of Excellence for Outstanding Research Park. This is the first time a member outside the US has been acknowledged. The announcement was made during AURP’s International Annual Conference in Baltimore (Maryland)...
Chosen by Independent Expert Panel at the 2018 Cambridge Independent Science and Technology Awards. Elpis Biomed Ltd. (Elpis), a University of Cambridge spin-out developing high quality human cells via its proprietary OPTi-OX platform, is pleased to announce that the Company has been selected as winner in the category Start-Up of the Year at the 2018 Cambridge Independent Science and Technology Awards...
New microscopy technologies, such as light sheet fluorescence microscopy (LSFM) or clearing methods, allow the imaging of large samples at high resolution or high frame rates. Handling, processing, and analyzing these multi-terabyte data sets has become increasingly difficult for scientists, e.g. in developmental biology and neuroscience. New tools are needed to overcome these challenges. Therefore, EISS has teamed up with arivis AG to offer complete solutions from initial image acquisition to final results...
Markes International’s outstanding success in exporting scientific instrumentation has been rewarded with an accolade from the UK’s Department for International Trade (DIT). The Board of Trade Awards, which are nominated and selected by the DIT, were this year awarded to eight Welsh businesses showing exceptional innovation, delivering prosperity to their local communities, and championing free trade...
Oxford Gene Technology (OGT), The Molecular Genetics Company, has announced that it has expanded its direct sales of Cytocell Fluorescence In Situ Hybridisation (FISH) products to include the Asia-Pacific (APAC) region. OGT will provide customers in Singapore, Malaysia, Vietnam, Australia, and New Zealand with enhanced local sales and support services via established affiliates of Sysmex Corporation, as well as via continued collaboration with existing distributors...
David Raunig, PhD brings decades of pharmaceutical research experience. ERT, a global data and technology company that minimizes uncertainty and risk in clinical trials, has announced the addition of David Raunig, PhD to its team of scientific and technological imaging experts. The science team is a key component of ERT’s rapidly growing advanced technology imaging solution, which has been used in more than 500 clinical studies to date...
For scientists who are looking for targeted exploration of new applications in the therapy of microbial and viral infection, cancer, and sepsis, now they can easily find antimicrobial peptides (AMPs) synthesis service at Creative Peptides. With extensive experience in the development, registration, production and post-launch support of peptides during the last two decades and more, Creative Peptides can offer a wide range of AMPs to fully support scientists’ projects. High quality and flexible scale are ensured....
Sygnature Discovery, a leading independent integrated drug discovery and pre-clinical services company, has today announced a multi-target, integrated drug discovery collaboration with Sitryx Therapeutics, a biopharmaceutical company focused on regulating cell metabolism to develop disease-modifying therapeutics in immuno-oncology and immuno-inflammation. The energetic status of cells has been shown to be pivotal in controlling the...
ERS Genomics Limited and DefiniGEN Ltd announced today a license agreement to provide DefiniGEN with access to ERS Genomic’s CRISPR/Cas9 genome editing technology patents. DefiniGEN will combine their best-in-class iPSC (induced Pluripotent Stem Cell) differentiation platform with CRISPR/Cas9 technology to generate a range of innovative preclinical human models. "The company’s gene editing technical portfolio has been further strengthened by licensing of this cutting-edge technology and will allow us....
SLS has been identified as one of London Stock Exchange Group’s 1000 Companies to Inspire Europe. The report is a celebration of high-growth and most dynamic small and medium sized businesses across Europe. To be included in the list, companies needed to show consistent revenue growth over a minimum of three years, significantly outperforming their country peers. More detail on the methodology can be found in the report online....
The UK’s Artificial Intelligence revolution gets new backing, as the Business Secretary announces five new centres of excellence for digital pathology and imaging, including radiology, using AI medical advances. The centres will use AI, an area the government is backing in its modern Industrial Strategy, to find new ways to speed up diagnosis of diseases to improve outcomes for patients. The centres will be spearheaded by some of the UK’s leading medical companies including GE Healthcare, Siemens, Philips, Leica, Canon and Roche Diagnostics.....jpg)
Optibrium™, a developer of software for drug discovery, has announced it had entered into a collaboration with the University of Nottingham, a pioneering research institution and university. Optibrium’s StarDrop™ software will be available to a number of 4th year MSci Chemistry project students at the University of Nottingham as part of their training in modern drug discovery to aid in the design of potential new candidate compounds for integrin inhibition in fibrotic diseases and malaria, as part of their collaboration with GSK....
How do you package your send-away pathology samples? Are you spending too much time and money on packaging your samples correctly? If you are currently wrapping tubes and using boxes to transport samples by courier or Royal Mail, this could be costing you a lot more and taking much longer than necessary. The Transport of Dangerous Goods Regulations require patient specimens and other biological samples to be transported according to UN3373 Biological Substance Category B, P650 Packaging Instruction...
With the concerted efforts of its scientists, BOC Sciences recently released fluorescent labeling service to facilitate the research work in the scientific community, adding to its already existing service portfolio encompassing custom synthesis, process R&D, bioconjugation, carbohydrate synthesis, and more. Fluorescent labelling is the process of covalently binding fluorescent dyes to biomolecules such as nucleic acids or proteins so that they can be visualized by fluorescence imaging....
Lab Innovations, the UK’s only trade show dedicated to the laboratory industry, beat all records for the show, attracting 3,113 attendees - a 10% increase on the previous year. Underlying the headline number were significant increases in visitors involved in purchasing products and services. Overall, 79% of visitors were involved in the purchasing decision, with a 43% increase in lab managers, a 53% increase in lab technicians, and an impressive 125% increase in procurement managers. In addition, the number of scientists attending increased by 49%...
Scotland is to have its own £15.8m artificial intelligence health research centre, which promises to enable better patient diagnosis, treatment and outcomes. The Industrial Centre for Artificial Intelligence Research in Digital Diagnostics, to be known as iCAIRD, brings together a pan-Scotland collaboration of 15 partners from across academia, the NHS, and industry. Greg Clark, UK Secretary of State for Business, Energy and Industrial Strategy (BEIS), announced that UK Research and Innovation will invest £10million in iCAIRD...
Oxford HighQ, a spinout from Oxford University, aims to revolutionise chemical and nanoparticle sensor technology with ‘quantum’ sensors up to 10,000 times more sensitive than current counterparts. Oxford HighQ, a quantum technologies spinout from Oxford University, has launched with £2.1m in seed funding to commercialise components of quantum computing technology developed at the University, providing a step change in performance for chemical and nanoparticle sensing....
BioAscent’s COO, Sylviane Boucharens named in top 50 Movers and Shakers in BioBusiness. BioAscent Discovery Limited’s COO, Dr Sylviane Boucharens, has been included in the BioBeat 2018 list of 50 Movers and Shakers in BioBusiness. Her nomination follows an incredibly successful year in which she has spearheaded the company’s expansion to become a fully integrated drug discovery CRO. Co-founded by Dr Boucharens in 2013, BioAscent initially focused on compound management....
Absolute Antibody Ltd., specialists in antibody sequencing, engineering and recombinant expression with a vision to make recombinant antibody technology accessible to all, has announced the opening of a new facility in northeast England. The new facility more than doubles Absolute Antibody’s laboratory space and will enable an even greater increase in its antibody production capacity, allowing the company to better service customers and accelerate the expansion of its recombinant antibody portfolio....
Platform Patent for Clustering a Subset of Antigens for Diagnosing Diseases. ImmunArray, a molecular diagnostic company co-headquartered in Rehovot, Israel and Richmond, Virginia, whose novel blood tests are pioneering new and more accurate ways to diagnose diseases detected by changes in the immune system, has announced that the U.S. Patent and Trademark Office (USPTO) recently issued a new patent that covers one of ImmunArray’s core diagnostic protocols – generic methods.....jpg)
Frost & Sullivan has presented INTEGRA Biosciences with the ‘2018 Global Laboratory Pipetting Company of the Year’ award, recognizing its products as innovative, revolutionary and able to fulfil the needs of customers. Frost & Sullivan’s transformational health research group conducted extensive research using key benchmarking criteria across two main areas – visionary impact and performance, and customer impact – to compare companies in the industry, and found that INTEGRA surpassed the competition....
The biocluster located in the Greater Paris region is the first European park to receive the Association of University Research Parks (AURP) award. Genopole, a French biocluster dedicated to research in the fields of genetics and biotechnology, today announces it has received the AURP Award of Excellence for Outstanding Research Park. This is the first time a member outside the US has been acknowledged. The announcement was made during AURP’s International Annual Conference in Baltimore (Maryland)...